Want to join the conversation?
$PFE's revenue from Innovative Products for 4Q15 rose by 15% from last year with Global Innovative Pharmaceuticals (GIP) revenue rising 10% operationally due to the strong operational performance of Eliquis globally. Established Products revenue fell 2% while Global Established Pharmaceutical (GEP) revenue rose 5% operationally.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.